Literature DB >> 20146693

Neurological complications of immune reconstitution in HIV-infected populations.

Tory Johnson1, Avindra Nath.   

Abstract

The introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection has transformed this disease from a fatal infection to a chronic yet manageable condition by restoring immune function. All the same, this restoration of immune response in some may be associated with deterioration in clinical status, which has been termed immune reconstitution inflammatory syndrome (IRIS). This syndrome often occurs in the context of an underlying opportunistic infection and develops after an interval of weeks to months after the initiation of HAART. Occasionally, IRIS may occur in the brain without any opportunistic infection, which presents as a T cell-mediated encephalitis. This paradoxical infiltration of previously immune suppressed patients with T cells represents a diagnostic challenge and a treatment dilemma. Nonetheless, CNS-IRIS with or without an opportunistic infection can range in severity. Severe cases can be fatal and hence require intervention with steroid treatment. This review discusses the diagnosis, clinical manifestations, risk factors, pathophysiology, and potential treatment strategies of the various forms of IRIS that involve the nervous system.

Entities:  

Mesh:

Year:  2010        PMID: 20146693     DOI: 10.1111/j.1749-6632.2009.05111.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  28 in total

1.  Fungal infections of the central nervous system.

Authors:  Claire S Jacobs; Mark R Etherton; Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 2.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.

Authors:  Lakshmanan Annamalai; Veena Bhaskar; Douglas R Pauley; Heather Knight; Kenneth Williams; Margaret Lentz; Eva Ratai; Susan V Westmoreland; R Gilberto González; Shawn P O'Neil
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 4.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy.

Authors:  Dennis Kolson
Journal:  Top Antivir Med       Date:  2017 Jul/Aug

Review 6.  Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Authors:  Christie M Lincoln; Peter Fata; Susan Sotardi; Michael Pohlen; Tomas Uribe; Jacqueline A Bello
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

7.  Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.

Authors:  Christine Fennema-Notestine; Ronald J Ellis; Sarah L Archibald; Terry L Jernigan; Scott L Letendre; Randy J Notestine; Michael J Taylor; Rebecca J Theilmann; Michelle D Julaton; David J Croteau; Tanya Wolfson; Robert K Heaton; Anthony C Gamst; Donald R Franklin; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Igor Grant
Journal:  J Neurovirol       Date:  2013-07-10       Impact factor: 2.643

8.  Neuroinfectious diseases: a crisis in neurology and a call for action.

Authors:  Avindra Nath
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

Review 9.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

10.  Metabolic profile of PML lesions in patients with and without IRIS: an observational study.

Authors:  Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Robert E Lenkinski; Igor J Koralnik
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.